Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Diego, CA
NPI
1760406649
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
12395 El Camino Real, Suite 317
San Diego, CA, 92130
Phone (858) 794-1250
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
18,611 services
Medicare patients, 2024
495
Average age 72
Drug cost, 2024
$1.3M
3,074 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael W Lee was code 99214 (office e&m - established), 743 times for 408 patients. In total Michael W Lee billed 18,611 services in 14 codes, and Medicare paid $94K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 743 | 408 | $97.35 | $72K |
| 99204 Office E&M - New | Office | 76 | 76 | $120.65 | $9,170 |
| 83036 Blood Count | Office | 32 | 16 | $9.52 | $305 |
| 99213 Office E&M - Established | Office | 30 | 22 | $60.47 | $1,814 |
| 99215 Office E&M - Established | Office | 17 | 17 | $124.57 | $2,118 |
By year: 2022 $77K for 18,172 services; 2023 $86K for 18,064 services; 2024 $94K for 18,611 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 32 | 16 | $9.52 | $305 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael W Lee prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 433 prescriptions and refills. In total Michael W Lee wrote 3,074 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Er Metformin Hcl | 433 | 928 | 120 | $3,343 |
| Mounjaro Tirzepatide | 330 | 368 | 51 | $369K |
| Ozempic Semaglutide | 304 | 421 | 63 | $381K |
| Levothyroxine Sodium Generic | 162 | 384 | 38 | $2,376 |
| Metformin Hcl Generic | 101 | 284 | 30 | $1,326 |
| Bupropion Hcl Sr Bupropion Hcl | 89 | 146 | 28 | $2,437 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 73 | 150 | 21 | $12K |
| Synthroid Levothyroxine Sodium | 66 | 185 | 22 | $8,808 |
| Trulicity Dulaglutide | 55 | 73 | 12 | $70K |
| Glipizide Er Glipizide | 52 | 142 | 14 | $1,037 |
| Rybelsus Semaglutide | 52 | 96 | 13 | $89K |
| Jardiance Empagliflozin | 46 | 108 | 12 | $58K |
| Humalog Kwikpen U-100 Insulin Lispro | 44 | 100 | 18 | $12K |
| Tresiba Flextouch U-100 Insulin Degludec | 40 | 55 | Under 11 | $24K |
| Liothyronine Sodium Generic | 35 | 79 | Under 11 | $2,999 |
Brand drugs: 1,394 claims; generic drugs: 1,522 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Michael W Lee were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.